Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.130 | 3.300 | 2.170 |
Shares | 98.880 | 98.880 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.986 | 21.892 |
Price to Book | 4.039 | 4.021 |
Price to Sales | 1.958 | 2.277 |
Price to Cash Flow | 14.420 | 17.046 |
Dividend Yield | 1.068 | 1.338 |
5 Years Earnings Growth | 11.866 | 11.286 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 98.630 | 94.888 |
Basic Materials | 1.370 | 1.279 |
Number of long holdings: 72
Number of short holdings: 4
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk A/S Class B | DK0060534915 | 5.90 | - | - | |
Pfizer | US7170811035 | 5.30 | 28.56 | +0.11% | |
Eli Lilly | US5324571083 | 5.13 | 803.17 | +2.55% | |
UnitedHealth | US91324P1021 | 5.10 | 523.55 | +1.22% | |
AstraZeneca | GB0009895292 | 4.43 | 12,364.0 | +2.22% | |
J&J | US4781601046 | 4.00 | 151.24 | -0.02% | |
Boston Scientific | US1011371077 | 2.94 | 75.67 | +0.41% | |
Thermo Fisher Scientific | US8835561023 | 2.56 | 590.12 | -0.65% | |
Vertex | US92532F1003 | 2.54 | 442.00 | -0.87% | |
Daiichi Sankyo | JP3475350009 | 2.31 | 5,453.0 | -0.78% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
SEB Sverige Indexfond | 41.23B | 7.66 | 4.68 | 10.72 | ||
SEB Varldenfond | 41.23B | 5.31 | 9.09 | 7.77 | ||
SEB Sverige Indexfond utd | 41.23B | 7.28 | 5.58 | 10.88 | ||
SEB Sverige Indexfond Institutional | 41.23B | 7.69 | 11.26 | - | ||
SEB Sverige Smabol C R utd | 25.21B | 8.40 | 7.44 | 17.87 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review